Cargando…

Increased expression of osteopontin in subchondral bone promotes bone turnover and remodeling, and accelerates the progression of OA in a mouse model

Osteopontin (OPN) has been proved to be closely related to the pathogenesis of osteoarthritis (OA), but the role of OPN in the pathogenesis of OA has not been fully clarified. Current studies on OPN in OA mostly focus on articular cartilage, synovial membrane and articular fluid, while ignoring its...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chuangxin, Chen, Zhong, Guo, Dong, Zhou, Laixi, Lin, Sipeng, Li, Changchuan, Li, Shixun, Wang, Xinjia, Lin, Bendan, Ding, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791213/
https://www.ncbi.nlm.nih.gov/pubmed/34982732
http://dx.doi.org/10.18632/aging.203707
_version_ 1784640157264117760
author Lin, Chuangxin
Chen, Zhong
Guo, Dong
Zhou, Laixi
Lin, Sipeng
Li, Changchuan
Li, Shixun
Wang, Xinjia
Lin, Bendan
Ding, Yue
author_facet Lin, Chuangxin
Chen, Zhong
Guo, Dong
Zhou, Laixi
Lin, Sipeng
Li, Changchuan
Li, Shixun
Wang, Xinjia
Lin, Bendan
Ding, Yue
author_sort Lin, Chuangxin
collection PubMed
description Osteopontin (OPN) has been proved to be closely related to the pathogenesis of osteoarthritis (OA), but the role of OPN in the pathogenesis of OA has not been fully clarified. Current studies on OPN in OA mostly focus on articular cartilage, synovial membrane and articular fluid, while ignoring its role in OA subchondral bone turnover and remodeling. In this study, we used a destabilization OA mouse model to investigate the role of OPN in OA subchondral bone changes. Our results indicate that increased expression of OPN accelerates the turnover and remodeling of OA subchondral bone, promotes the formation of h-type vessels in subchondral bone, and mediates articular cartilage degeneration induced by subchondral bone metabolism. In addition, our results confirmed that inhibition of PI3K/AKT signaling pathway inhibits OPN-mediated OA subchondral bone remodeling and cartilage degeneration. This study revealed the role and mechanism of OPN in OA subchondral bone, which is of great significance for exploring specific biological indicators for early diagnosis of OA and monitoring disease progression, as well as for developing drugs to regulate the metabolism and turnover of subchondral bone and alleviate the subchondral bone sclerosis of OA.
format Online
Article
Text
id pubmed-8791213
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-87912132022-01-27 Increased expression of osteopontin in subchondral bone promotes bone turnover and remodeling, and accelerates the progression of OA in a mouse model Lin, Chuangxin Chen, Zhong Guo, Dong Zhou, Laixi Lin, Sipeng Li, Changchuan Li, Shixun Wang, Xinjia Lin, Bendan Ding, Yue Aging (Albany NY) Research Paper Osteopontin (OPN) has been proved to be closely related to the pathogenesis of osteoarthritis (OA), but the role of OPN in the pathogenesis of OA has not been fully clarified. Current studies on OPN in OA mostly focus on articular cartilage, synovial membrane and articular fluid, while ignoring its role in OA subchondral bone turnover and remodeling. In this study, we used a destabilization OA mouse model to investigate the role of OPN in OA subchondral bone changes. Our results indicate that increased expression of OPN accelerates the turnover and remodeling of OA subchondral bone, promotes the formation of h-type vessels in subchondral bone, and mediates articular cartilage degeneration induced by subchondral bone metabolism. In addition, our results confirmed that inhibition of PI3K/AKT signaling pathway inhibits OPN-mediated OA subchondral bone remodeling and cartilage degeneration. This study revealed the role and mechanism of OPN in OA subchondral bone, which is of great significance for exploring specific biological indicators for early diagnosis of OA and monitoring disease progression, as well as for developing drugs to regulate the metabolism and turnover of subchondral bone and alleviate the subchondral bone sclerosis of OA. Impact Journals 2022-01-04 /pmc/articles/PMC8791213/ /pubmed/34982732 http://dx.doi.org/10.18632/aging.203707 Text en Copyright: © 2021 Lin et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Lin, Chuangxin
Chen, Zhong
Guo, Dong
Zhou, Laixi
Lin, Sipeng
Li, Changchuan
Li, Shixun
Wang, Xinjia
Lin, Bendan
Ding, Yue
Increased expression of osteopontin in subchondral bone promotes bone turnover and remodeling, and accelerates the progression of OA in a mouse model
title Increased expression of osteopontin in subchondral bone promotes bone turnover and remodeling, and accelerates the progression of OA in a mouse model
title_full Increased expression of osteopontin in subchondral bone promotes bone turnover and remodeling, and accelerates the progression of OA in a mouse model
title_fullStr Increased expression of osteopontin in subchondral bone promotes bone turnover and remodeling, and accelerates the progression of OA in a mouse model
title_full_unstemmed Increased expression of osteopontin in subchondral bone promotes bone turnover and remodeling, and accelerates the progression of OA in a mouse model
title_short Increased expression of osteopontin in subchondral bone promotes bone turnover and remodeling, and accelerates the progression of OA in a mouse model
title_sort increased expression of osteopontin in subchondral bone promotes bone turnover and remodeling, and accelerates the progression of oa in a mouse model
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791213/
https://www.ncbi.nlm.nih.gov/pubmed/34982732
http://dx.doi.org/10.18632/aging.203707
work_keys_str_mv AT linchuangxin increasedexpressionofosteopontininsubchondralbonepromotesboneturnoverandremodelingandacceleratestheprogressionofoainamousemodel
AT chenzhong increasedexpressionofosteopontininsubchondralbonepromotesboneturnoverandremodelingandacceleratestheprogressionofoainamousemodel
AT guodong increasedexpressionofosteopontininsubchondralbonepromotesboneturnoverandremodelingandacceleratestheprogressionofoainamousemodel
AT zhoulaixi increasedexpressionofosteopontininsubchondralbonepromotesboneturnoverandremodelingandacceleratestheprogressionofoainamousemodel
AT linsipeng increasedexpressionofosteopontininsubchondralbonepromotesboneturnoverandremodelingandacceleratestheprogressionofoainamousemodel
AT lichangchuan increasedexpressionofosteopontininsubchondralbonepromotesboneturnoverandremodelingandacceleratestheprogressionofoainamousemodel
AT lishixun increasedexpressionofosteopontininsubchondralbonepromotesboneturnoverandremodelingandacceleratestheprogressionofoainamousemodel
AT wangxinjia increasedexpressionofosteopontininsubchondralbonepromotesboneturnoverandremodelingandacceleratestheprogressionofoainamousemodel
AT linbendan increasedexpressionofosteopontininsubchondralbonepromotesboneturnoverandremodelingandacceleratestheprogressionofoainamousemodel
AT dingyue increasedexpressionofosteopontininsubchondralbonepromotesboneturnoverandremodelingandacceleratestheprogressionofoainamousemodel